Correction: Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic
- PMID: 35482453
- PMCID: PMC9832883
- DOI: 10.20945/2359-3997000000469
Correction: Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic
Erratum for
-
Use of unconventional antithyroid therapy in patients with thiamazole agranulocytosis in the context of the COVID-19 pandemic.Arch Endocrinol Metab. 2022 Mar 8;66(1):132-133. doi: 10.20945/2359-3997000000453. Arch Endocrinol Metab. 2022. PMID: 35263055 Free PMC article. No abstract available.
Publication types
LinkOut - more resources
Full Text Sources